TMUNITY THERAPEUTICS
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. Tmunity is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit best-in-class control over T cell activation and direction in vivo, as well as proprietary technologies to activate, expand, and genetically engineer T cells from peripheral blood, cord blood and tumors... . The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease. The founding team includes experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, who collectively have an unparalleled track record of executing safe and effective cell and gene therapy clinical trials. In addition, Tmunity’s manufacturing platform has a proven track record of success in supporting multi-center clinical studies across diverse therapeutic indications.
TMUNITY THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Manufacturing Therapeutics
Founded:
2015-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.tmunity.com
Total Employee:
51+
Status:
Active
Contact:
215-966-1600
Total Funding:
230 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Silk Therapeutics
Silk Therapeutics is a biotech company that offers skincare products for human health and wellness.
Current Advisors List
Current Employees Featured
Founder
Investors List
Andreessen Horowitz
Andreessen Horowitz investment in Series B - Tmunity Therapeutics
BrightEdge Fund
BrightEdge Fund investment in Series B - Tmunity Therapeutics
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program investment in Series B - Tmunity Therapeutics
Westlake Village BioPartners
Westlake Village BioPartners investment in Series B - Tmunity Therapeutics
Be The Match BioTherapies
Be The Match BioTherapies investment in Series B - Tmunity Therapeutics
University of Pennsylvania
University of Pennsylvania investment in Series B - Tmunity Therapeutics
Gilead Sciences
Gilead Sciences investment in Series B - Tmunity Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - Tmunity Therapeutics
Be The Match BioTherapies
Be The Match BioTherapies investment in Series A - Tmunity Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series A - Tmunity Therapeutics
Official Site Inspections
http://www.tmunity.com Semrush global rank: 8.56 M Semrush visits lastest month: 290
Unable to get host informations!!!
More informations about "Tmunity Therapeutics"
Tmunity Therapeutics - Crunchbase Company Profile
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. Tmunity is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells …See details»
Kite Completes Acquisition of Tmunity - Gilead Sciences
Feb 22, 2023 The acquisition of Tmunity complements Kite’s existing in-house cell therapy research capabilities by adding additional pipeline assets, platform capabilities, and a strategic …See details»
Gilead Sciences, Inc. - Kite Completes Acquisition of Tmunity
Feb 22, 2023 Kite, a Gilead Company (NASDAQ: GILD), today announced the completion of the previously announced transaction to acquire Tmunity Therapeutics (Tmunity), a clinical-stage, …See details»
Kite to Acquire Tmunity Therapeutics to Pursue Next ... - Kite Pharma
Dec 20, 2022 Tmunity is a private, clinical-stage biotechnology company focused on transforming the future of CAR-T therapies by developing the next generation of engineered T …See details»
Tmunity Therapeutics Incorporated - LinkedIn
Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has more patient experience ...See details»
Tmunity Company Profile 2024: Valuation, Investors, Acquisition
When was Tmunity founded? Tmunity was founded in 2009. Where is Tmunity headquartered? Tmunity is headquartered in Philadelphia, PA. What is the size of Tmunity? Tmunity has 27 …See details»
Kite Pharma acquires Tmunity Therapeutics - Crunchbase
Feb 22, 2022 Acquired Organization: Tmunity Therapeutics Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells. Acquiring Organization: Kite …See details»
Kite Buys Tmunity To Chase Next-Generation CAR T-Cell Therapies
Dec 21, 2022 Tmunity’s armored T-cell platform engineers patients’ cells to be more durable and effective. The company has at least seven programs in development, with four in the clinical …See details»
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation
Dec 20, 2022 Tmunity was formed in 2015 by some of the early innovators in the cell therapy field, the University of Pennsylvania’s Dr. June, Bruce Levine, PhD, James Riley, PhD and …See details»
Gilead's Kite swoops in to buy CAR-T focused Tmunity - Fierce …
Dec 20, 2022 Tantalizing Kite was Tmunity’s CAR-T platform, which has been designed to further refine patients' modulated cells to be more durable and more effective, as well as an …See details»
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation …
Dec 20, 2022 Tmunity was formed in 2015 by some of the early innovators in the cell therapy field, the University of Pennsylvania’s Dr. June, Bruce Levine, PhD, James Riley, PhD and …See details»
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation …
Dec 20, 2022 Tmunity is a private, clinical-stage biotechnology company focused on transforming the future of CAR-T therapies by developing the next generation of engineered T …See details»
Gilead buys Tmunity, cozying up to a CAR-T pioneer
Dec 20, 2022 Dive Insight: Tmunity was founded in 2015 by a team of cell therapy experts, including CAR-T pioneer Carl June.By early 2018, the company and its technology, which …See details»
Kite to buy Tmunity, expanding its CAR T pipeline
Dec 22, 2022 Tmunity’s founders Dr Carl June, Bruce Levine, PhD, James Riley, PhD and Anne Chew, PhD from the University of Pennsylvania – will become paid senior scientific advisors …See details»
Tmunity Therapeutics - Craft
Tmunity Therapeutics is a biotherapeutics company focused on delivering the full potential of next-generation T cell immunotherapy to patients with devastating diseases. Using …See details»
Tmunity Therapeutics - Contacts, Employees, Board Members, …
Organization. Tmunity Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. Tmunity Therapeutics has 8 current employee profiles, …See details»
Why We’re Investing in Tmunity - Andreessen Horowitz
Oct 31, 2019 Tmunity has invested in its own state-of-the-art manufacturing facility to ensure it can make and scale its products. They are working with medical centers to offer logistical …See details»
Tmunity Therapeutics Raises $100 Million in Series A Financing to ...
Jan 23, 2018 Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of ... The organization is …See details»
Tmunity Therapeutics Is Pioneering Personalized Cancer Treatments
Oct 14, 2019 Tmunity is one of several local companies advancing current treatments and developing new therapies that have the potential to improve overall survival and reduce long …See details»
Tmunity dials series A round up to $135M to fuel progress of T …
Apr 19, 2018 Tmunity has added $35 million to its series A round, bringing its total haul up to $135 million. The cash sets ex-Novartis executive Usman “Oz” Azam up to build out the …See details»